Digital biomarkers are emerging as important predictive tools to support the global Covid-19 pandemic
Gilead Sciences has launched two Phase III clinical trials of its investigational antiviral drug remdesivir in the UK to treat Covid-19 patients.
Keeping the supply chain of life-saving and life-changing drugs functioning efficiently is demanding under normal circumstances, so the difficulties experienced during these unprecedented times are intensifying an already challenging predicament.
The European Medicines Agency (EMA) has urged that two malaria drugs, chloroquine and hydroxychloroquine, being tested as potential Covid-19 treatment must only be used for clinical trials or national emergency use programmes.
Challenges and risks associated with the recipe management process in the life sciences industry can be overcome by the introduction of MePIS RM software solution.
Cleaning validation is a requirement for pharmaceutical manufacturing, which adheres to current good manufacturing practice (cGMP) and quality systems regulations (QSR).
SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.
While transforming and re-focusing pharma towards long-term treatments, advanced therapies have also pose significant challenges to regulators who are trying to figure out how to approve and reimburse these innovative medicines. Allie Nawrat spoke to the Alliance for Regenerative Medicine about its recommendations for regulators in this complicated, ever-evolving space.
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.